Apellis Pharmaceuticals, Inc.

254900HS0ZFRXXSB9D42

The entity

Status: Active
LEI status: Lapsed - not renewed
Category: Company
Legal form: Corporation (XTIQ)
Jurisdiction: US-DE
Entity created: September 25, 2009

Address

Country: United States
Legal address: C/O Capitol Services, Inc., 108 Lakeland Ave.19901 DoverUnited States (US-DE)
Head office: 100 5th Avenue, Floor 302451 WalthamUnited States (US-MA)

Identifier

LEI: 254900HS0ZFRXXSB9D42
Registered: September 12, 2019 at 12:28 PM UTC
Last updated: August 20, 2026 at 01:30 PM UTC
Next renewal: August 20, 2026 at 11:44 AM UTC
Issuer: Bloomberg (5493001KJTIIGC8Y1R12)
Registered with: Division of Corporations, Department of State (RA000602)
Identifier: 4735405
Verified against: Division of Corporations, Department of State (RA000602)
Verified as: 4735405
Corroboration: Confirmed against a public register
GLEIF conformity: Does not meet the standard

Corporate structure

Why no parent is reported

No direct parent reportedNo ultimate parent reported: No owner is known to control it

Machine access

REST: https://lei.online/v1/entities/254900HS0ZFRXXSB9D42This record as JSON.
MCP: https://lei.online/mcpThe same data as an MCP tool.

Start a new search